Approval · Notice of Compliance 36836 · 2026
ONCOTICE: Notice of Compliance 36836
Issued February 2, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36836
- Date
- February 2, 2026
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph update.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONCOTICE | Not yet assigned | — |
Medicinal ingredients
- BACILLUS CALMETTE-GUERIN (BCG) STRAIN TICE 800,000,000 CFU per 15.5MG